Pulmonary Hypertension (PH) due to Pulmonary Embolism (PE) secondary to COVID19 – A District General Hospital (DGH) experience from the UK
I. Nadeem (Luton, United Kingdom), N. Mahdi (Luton, United Kingdom), M. Ur Rasool (Bury St Edmunds, United Kingdom), S. Radoja (Luton, United Kingdom), F. Rashad (Luton, United Kingdom), A. Babu (Luton, United Kingdom), N. Mahdi (London, United Kingdom)
Source: International Congress 2022 – Non-PAH pulmonary hypertension
Session: Non-PAH pulmonary hypertension
Session type: Thematic Poster
Number: 3452
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Nadeem (Luton, United Kingdom), N. Mahdi (Luton, United Kingdom), M. Ur Rasool (Bury St Edmunds, United Kingdom), S. Radoja (Luton, United Kingdom), F. Rashad (Luton, United Kingdom), A. Babu (Luton, United Kingdom), N. Mahdi (London, United Kingdom). Pulmonary Hypertension (PH) due to Pulmonary Embolism (PE) secondary to COVID19 – A District General Hospital (DGH) experience from the UK. 3452
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|